← Leaderboards
Gerald B Appel
Columbia University Health Sciences
$385,820
Attributed
$385,820
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$385,820 · 1
By mechanism
M01$385,820 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Jonathan M. Barasch$18,196,986
- Kazuhiko Yamada$21,077,647
- David H Sachs$52,326,282
- F. Xavier Pi-Sunyer$45,280,520
- H. Thomas Lee$13,317,904
Others in their field
Top investigators on “Angiotensin Ii”
- Mohan K. Raizada · University Of Florida$19,287,938
- Kenneth E Bernstein · Cedars-Sinai Medical Center$17,065,622
- Kafait U Malik · University Of Tennessee Health Sci Ctr$16,138,278
- David G Harrison · Vanderbilt University Medical Center$15,672,369
- Lisa A Cassis · University Of Kentucky$14,214,826
- Kathryn L Sandberg · Georgetown University$13,815,955
Research focus
Angiotensin IiClinical ResearchDiabetes Mellitus TherapyDiabetic AngiopathyDiabetic NephropathyDisease /Disorder Prevention /ControlHormone InhibitorHormone ReceptorHuman SubjectHuman Therapy EvaluationLosartanMedical ComplicationNoninsulin Dependent Diabetes MellitusProteinuriaRenal Failure
Grant awards (5)
EVALUATE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN NIDDM$192,910
M01 · FY2002 · RR
EVALUATE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN NIDDM$192,910
M01 · FY2001 · RR
EVALUATE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN NIDDM$0
M01 · FY2001 · RR
EVALUATE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN NIDDM$0
M01 · FY2000 · RR
EVALUATE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN NIDDM$0
M01 · FY2000 · RR